(4Z,7Z,10Z,13Z,19Z)-16,17-epoxydocosapentaenoic acid

Metabolite details

Identifier

BCTXZWCPBLWCRV-ZYADFMMDSA-N

InChI Key

BCTXZWCPBLWCRV-ZYADFMMDSA-N

IUPAC name

(4Z,7Z,10Z,13Z,19Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

Preferred name

(4Z,7Z,10Z,13Z,19Z)-16,17-epoxydocosapentaenoic acid

INN name

—

Synonym

16,17-EDP

ChEBI

CHEBI:72855

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Lipid mediators of inflammation in BALF 6-19 days after infection with influenza.
• Lipid mediators of inflammation in BALF 3-11 days after infection with influenza.
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice

Observed in differential profiles

• Control_vs_nsPEF_7_day
• Mock_19d_vs_PR8_19d
• G1_Mock_11_day_vs_G5_PR8_11_day
• G1_Mock_11_day_vs_G5_PR8_11_day
• G1_PBS_vs_G2_DSS